STOCK TITAN
  1. Home
  2. Sec-filings
  3. ARDT
  4. [Form 4] Ardent Health, Inc. Insider Trading Activity

Ardent Health (ARDT) director awarded 14,231 restricted stock units in Form 4

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Sen Rahul reported acquisition or exercise transactions in this Form 4 filing.

Ardent Health, Inc. director Rahul Sen reported an award of 14,231 shares of Common Stock in the form of restricted stock units. These units were granted at no cash cost and will vest in full on the first anniversary of April 1, 2026, contingent on his continued service. Following this compensation-related grant, Sen’s directly owned and awarded position totals 38,709 shares.

Positive

  • None.

Negative

  • None.
Insider Sen Rahul
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 14,231 $0.00 --
Holdings After Transaction: Common Stock — 38,709 shares (Direct)
Footnotes (1)
  1. [object Object]
RSU grant size 14,231 shares Restricted stock units awarded to director Rahul Sen
Grant price $0.0000 per share Equity compensation, not an open-market purchase
Post-transaction holdings 38,709 shares Total directly reported after the RSU grant
Vesting condition date reference First anniversary of April 1, 2026 Full vesting date for restricted stock units, service-based
restricted stock units financial
"Represents restricted stock units that vest in full on the first anniversary"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
vest in full financial
"restricted stock units that vest in full on the first anniversary"
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sen Rahul
(Last)(First)(Middle)
340 SEVEN SPRINGS WAY, SUITE 100
(Street)
BRENTWOOD TENNESSEE 37027
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Ardent Health, Inc. [ ARDT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/01/2026A14,231(1)A$038,709D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units that vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through the vesting date.
Remarks:
/s/ Stephen C. Petrovich, Attorney-in-Fact04/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Ardent Health (ARDT) disclose for Rahul Sen?

Ardent Health director Rahul Sen received an award of 14,231 restricted stock units. These units represent Common Stock granted as equity compensation, increasing his directly reported holdings to 38,709 shares after the transaction, according to the Form 4 filing.

Was the Ardent Health (ARDT) share award to Rahul Sen a market purchase?

No, the 14,231 shares were granted as a restricted stock unit award, not bought on the open market. The filing shows a grant with a price of $0.0000 per share, indicating equity compensation rather than a cash purchase.

When do Rahul Sen’s Ardent Health (ARDT) restricted stock units vest?

Rahul Sen’s restricted stock units vest in full on the first anniversary of April 1, 2026. The vesting is conditioned on his continued service with Ardent Health through that vesting date, as disclosed in the footnote to the Form 4.

How many Ardent Health (ARDT) shares does Rahul Sen hold after this grant?

After the 14,231-share restricted stock unit grant, Rahul Sen’s total directly reported holdings are 38,709 shares. This figure includes the newly awarded units, as shown in the post-transaction ownership column in the Form 4 filing.

What does transaction code "A" mean in the Ardent Health (ARDT) Form 4?

Transaction code “A” in this Form 4 indicates a grant, award, or other acquisition of securities. For Rahul Sen, it reflects an equity compensation grant of 14,231 restricted stock units rather than an open-market purchase or sale of Ardent Health shares.